THE DEAL, AT A GLANCE
From the announcementPolyphron
01Who is involvedBacked by Quiet Capital, Gradient, Haystack, CompoundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedPolyphron raised $20M Pre-SeedFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersPolyphron’s $20M Pre-Seed funds a platform that combines automated human micro-tissue growth with simulation-based tissue response prediction.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Polyphron · Financing Record
Explore source-linked visual explanations for Polyphron. Unsupported claims are withheld while source review continues.
Record 12637 · Recorded date: Needs review
What it does
Polyphron trains frontier AI models to manufacture and simulate donor-diverse human tissues to create the critical verification substrate for human biology.
Source: polyphron.com ↗